—Bothell, WA-based OncoGenex (NASDAQ: OGXI), a developer of cancer drugs, reached agreements to raise $9.5 million from institutional investors through a registered stock offering, as Luke reported. In May, the company presented data showing its prostate cancer drug, OGX-011, helped men live a median time of about 7 months longer when combined with chemotherapy, as compared to chemo alone.

—Seattle-based Blue Marble Energy has raised an undisclosed amount of Series A funding from unnamed investors, as Eric reported. The company is working on ways to convert algae and waste into useful chemicals and renewable fuel. In April, Blue Marble Energy closed approximately $1 million out of a $2 million equity offering, according to a regulatory filing.

—Bio Architecture Lab, a Seattle-based University of Washington spinout, raised $3.4 million in equity funding out of a $6 million offering. The investors were not disclosed. The stealth startup, which raised $1.5 million from X/Seed Capital last year, is using synthetic biology and computational enzyme design to make biofuels and renewable chemicals from relatively cheap, sustainable biomass sources.

—Portland, OR-based Blackbox Republic, a niche social network, has raised $1 million in seed funding from angel investors. Blackbox is led by former Jive Software exec Sam Lawrence. The company is targeting the sex positive community, and wants to fill the void between Facebook and Match.com.